Meeting
2022 ASCO Annual Meeting
Phase IB trial of pegylated arginine deiminase (ADI-PEG 20) plus radiotherapy and temozolomide in patients with newly diagnosed glioblastoma.
Authors
John S. Bomalaski
Polaris Pharmaceuticals Inc., San Diego, CA
John S. Bomalaski , Ko-Ting Chen , Ming-Jung Chuang , Chi-Ting Liau , Meng-Ting Peng , Pin-Yuan Chen , Cheng-Chi Lee , Amanda Johnston , Hui-Fen Liu , Ya-Lun S. Huang , Chih-Ling Kuo , Chiung-Fang Shiu , Peng-Wei Hsu , Chi-Cheng Chuan , Dar-Ming Lai , Kuo-Chen Wei
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Primary CNS Tumors–Glioma
Clinical Trial Registration Number
NCT04587830
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 2057)
DOI
10.1200/JCO.2022.40.16_suppl.2057
Abstract #
2057
Poster Bd #
395
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
First Author: Antonio Marcilio Padula Omuro
Poster
2015 ASCO Annual Meeting
Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
First Author: Alissa A. Thomas
Poster
2013 ASCO Annual Meeting
The Stupp regimen preceded by early post-surgery temozolomide versus the Stupp regimen alone in the treatment of patients with newly diagnosed glioblastoma multiforme (GBM).
First Author: LF Zhou
Poster
2011 ASCO Annual Meeting
CeCil: A randomized, noncomparative phase II clinical trial of the effect of radiation therapy (RT) plus temozolomide (TMZ) combined with cilengitide or cetuximab on the 1-year overall survival of patients with newly diagnosed MGMT-promoter unmethylated glioblastoma.
First Author: V. Verschaeve